Results 31 to 40 of about 9,502 (214)

Safety and Efficacy of Hypersonic Vitrectomy for Retinal Reattachment Surgery in Proliferative Vitreoretinopathies

open access: yesClinical Ophthalmology, 2022
Svenja Deuchler,1– 3 Julia Scholtz,1 Timo Knoch,4 Berthold Seitz,2 Frank H Koch1,3 1Study Centre, Augenzentrum Frankfurt, Frankfurt am Main, Hessen, Germany; 2Department of Ophthalmology, Saarland University Medical Center, Homburg, Saarland ...
Deuchler S   +4 more
doaj  

Clinical study on Hypotony following blunt ocular trauma

open access: yesInternational Journal of Ophthalmology, 2012
AIM: To evaluate the incidence and risk factors of hypotony in patients with blunt ocular trauma. METHODS: The medical records of 145 patients with blunt ocular trauma were reviewed. Hypotony was defined as an average intraocular pressure (IOP) of 5mmHg
Chun Ding, Jun Zeng
doaj   +1 more source

The Outcomes of Recurrent Retinal Detachment Surgery and the Effects of the First Surgeon to the Final Outcomes

open access: yesBoğaziçi Tıp Dergisi, 2020
INTRODUCTION[|]To evaluate the outcomes of vitreoretinal surgery in patients with recurrent retinal detachment (RD) and compare whether these outcomes differ regarding the surgeon who carried out the first surgery.[¤]METHODS[|]The medical records of the ...
Hatice Nur Tarakçıoğlu   +1 more
doaj   +1 more source

IGF-1 Regulates the extracellular level of active MMP-2 and promotes Müller glial cell motility [PDF]

open access: yes, 2015
In ischemic proliferative retinopathies, Müller glial cells (MGCs) acquire migratory abilities. However, the mechanisms that regulate this migration remain poorly understood.
Chiabrando, Gustavo Alberto   +4 more
core   +1 more source

Rhegmatogenous retinal detachment masquerading as exudative panuveitis with intense anterior chamber inflammatory reaction. [PDF]

open access: yes, 2020
Purpose:This is a retrospective case report illustrating the diagnostic and therapeutic challenges associated with a chronic rhegmatogenous retinal detachment masquerading as a severe panuveitis with intense anterior chamber inflammation.
Bhisitkul, Robert B   +3 more
core  

Adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): study protocol for a phase III, multi-centre, double-masked randomised controlled trial [PDF]

open access: yes, 2016
BACKGROUND: Eyes sustaining open globe trauma are at high risk of severe visual impairment. Ocular injuries which result in visual loss invariably affect the posterior segment of the eye, and prevention of visual loss involves posterior segment ...
Caroline Murphy   +9 more
core   +6 more sources

Pseudohipópio pós-injeção intravítrea de triancinolona: relato de casos [PDF]

open access: yes, 2005
Report on the development of pseudohypopyon immediately after intravitreal injection of triamcinolone acetonide (TAAC). Two phakic patients presenting with a transient pseudohypopyon after having been treated with intravitreal triamcinolone.
Belfort, Rubens Junior [UNIFESP]   +3 more
core   +3 more sources

p21CIP/WAF1 saRNA inhibits proliferative vitreoretinopathy in a rabbit model.

open access: yesPLoS ONE, 2023
PurposeProliferative vitreoretinopathy (PVR) is a disease process resulting from proliferation of retinal pigment epithelial (RPE) cells in the vitreous and periretinal area, leading to periretinal membrane formation and traction and eventually to ...
Qi Zhang   +7 more
doaj   +2 more sources

Thrombin Generation in Vitreous and Subretinal Fluid of Patients with Retinal Detachment [PDF]

open access: yes, 2018
Purpose: To measure prothrombin fragments (F1+2) and thrombin-antithrombin complex (TAT) in vitreous and subretinal fluid (SRF) of rhegmatogenous retinal detachment (RRD) patients and to validate and further specify our earlier finding of increased ...
Bastiaans, J. (Jeroen)   +4 more
core   +1 more source

Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy

open access: yesMediators of Inflammation, 2004
PURPOSE: To investigate whether caffeic acid phenethyl ester (CAPE) and cortisone prevent proliferative vitreoretinopathy (PVR).
Yusuf Turkoz   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy